Skip to main content
. 2015 Oct 23;2015(10):CD008572. doi: 10.1002/14651858.CD008572.pub2

Summary of findings 3. Discs: radiofrequency denervation versus placebo.

Discs: radiofrequency denervation versus placebo
Patient or population: patients with chronic low back pain
 Settings: secondary care
 Intervention: discs: radiofrequency denervation
 Comparision: placebo
Outcomes Illustrative comparative risks* (95% CI) Relative effect
 (95% CI) Number of participants
 (studies) Quality of the evidence
 (GRADE) Comments
Assumed risk Corresponding risk
Placebo Radiofrequency denervation
Pain 1 month post treatment (VAS 0 to 10) Pain score in control group was
5.7
Pain score in intervention groups was
 0.4 lower 
 (1.5 lower to 0.7 higher)   56
 (1 study) ⊕⊕⊝⊝
 Lowa,b  
Pain 1 to 6 months post treatment (VAS 0 to 10) Mean pain score ranged across control groups from
4.4 to 5.9
Mean pain score in intervention groups was on average
 0.3 higher 
 (2.3 lower to 2.8 higher)   84
 (2 studies) ⊕⊕⊝⊝
 Lowb,c  
Pain > 6 months post treatment (VAS 0 to 10) Mean pain score ranged across control groups from
5.3 to 6.6
Mean pain score in intervention groups was on average
 0.8 lower 
 (1.2 to 0.3 lower)   75
 (2 studies) ⊕⊕⊕⊝
 Moderateb  
Function 1 month post treatment (ODI 0 to 100) Functional status in control
 group was
39.9
Mean function in intervention groups was on average
 1.0 higher 
 (6.9 lower to 8.9 higher)   57
 (1 study) ⊕⊕⊝⊝
 Lowa,b  
Function 1 to 6 months post treatment (ODI 0 to 100) Mean functional status ranged across control
 groups from
 36.7 to 40.4 Mean functioning in intervention groups was on average
 0.9 higher 
 (6.4 lower to 8.1 higher)   85
 (2 studies) ⊕⊕⊕⊝
 Moderateb  
Function > 6 months post treatment (ODI 0 to 100) Mean functional status ranged across control
 groups from
28.2 to 41.2
Mean functioning in intervention groups was on average
 6.8 lower 
 (13.4 to 0.1 lower)   76
 (2 studies) ⊕⊕⊕⊝
 Moderateb  
CI: Confidence interval; VAS: Visual analogue scale.
GRADE Working Group grades of evidence.
 High quality: Further research is very unlikely to change our confidence in the estimate of effect.
 Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
 Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
 Very low quality: We are very uncertain about the estimate.

aSingle study, in any case inconsistent.
 bFewer than 400 participants included.
 cI2 > 50%.